Clinical Trials Directory

Trials / Completed

CompletedNCT00326534

Rickettsial Genesis to Sarcoidosis in Denmark

Status
Completed
Phase
Study type
Observational
Enrollment
36 (actual)
Sponsor
Statens Serum Institut · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

One study has suggested a connection between an infection with Rickettsia species and sarcoidosis finding molecular evidence of rickettsial deoxyribonucleic acid (DNA) in two patients. Another study found no antibodies in twenty Swedish patients with sarcoidosis. This study will further enhance the subject by three different approaches in Danish patients. The purpose of this study is to find serological and molecular evidence of an infection with Rickettsia species in Danish patients with sarcoidosis.

Detailed description

The study has three approaches to the subject: 1. A serological survey of rickettsial immunoglobin G (IgG)-antibodies in 50 patients with sarcoidosis compared to 50 blood donors without sarcoidosis. 2. An archival study using pre-existing lymph node biopsies, where immunohistochemical analysis, fluorescent in situ hybridization, and polymerase chain reaction will be applied to samples from 50 patients with sarcoidosis and compared to 50 patients without sarcoidosis and 10 patients with tuberculosis. 3. A prospective study using bronchoscopically obtained samples from 20 patients with sarcoidosis, compared to 20 patients without sarcoidosis. The study applies the same techniques as the second study, but enhancing the information from the patients.

Conditions

Timeline

Start date
2006-09-01
Primary completion
2009-01-01
Completion
2009-03-01
First posted
2006-05-17
Last updated
2009-03-09

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00326534. Inclusion in this directory is not an endorsement.